Dossier · MRAM · Dormant
MRAM · Everspin Technologies, Inc.
Last analysed ·
Current thesis
Post-parabolic markdown: the AI-memory story behind a +300% run is breaking. Kerrisdale short (2026-05-19, $14 PT) reframed MRAM's top market as casino slot machines, not AI; price rolling ~$29 (06-04) → ~$23 (06-06) below every analyst PT (~$18); Director Finch dumped $8.5M of stock on 06-02. Squeeze unwinding, not a setup.
Invalidation trigger
Daily close below $22 (loses the 06-06 ~$23.03 low) confirms the post-parabolic markdown; with heavy insider distribution (Finch 310,091 sh @ ~$27.47, 06-02) and price still above all PTs (~$18), any AI-memory premium continues unwinding toward the $14–$18 target cluster.
Thesis status
Open commitment scored if the trigger above fires How this is scored →Current Thesis
The AI-memory narrative that powered a +300% run (52-week range $5.64–$51.50) is breaking, and the tape is now confirming it. Kerrisdale Capital disclosed a short on 2026-05-19 with a $14 price objective, arguing the rally is disconnected from a business whose largest end market is casino gaming and slot machines not hyperscalers or AI servers with revenue stuck in a $50–65M annual band for years. Price is rolling over: ~$29.25 on 06-04 to a $23.03–$27.99 range on 06-06, closing ~$23.05, still above every published analyst PT ($17.5–$18.5, avg $18) and far above Kerrisdale's $14. This is a late-stage squeeze unwinding, not an accumulation base a chase trap, not a fresh long.
Bull Case
- Q1 2026 (reported 2026-04-29): revenue $14.9M, +14% YoY, beat the $14.63M estimate; MRAM product sales $14.1M, +28% YoY and +5% sequentially.
- Gross margin lifted to 52.7% on better mix and yields; adjusted net income $2.6M vs a $1.2M loss a year prior.
- New $40M, 2.5-year defense subcontract (Toggle MRAM process tech to the US Defense Industrial Base) real diversification away from industrial/embedded, plus $2.1M of other income booked in Q1.
- Q2 2026 guide $15.5–16.5M implies continued sequential growth.
- Roadmap: high-reliability 128Mb/256Mb UNISYST MRAM parts targeted for H2 2026, engineering samples late 2026.
- Cash $40.5M with low debt a survivable balance sheet for a ~$60M-revenue microcap, and a tight float that fuels squeezes on any positive headline.
Bear Case
- Kerrisdale (2026-05-19) $14 PT = ~63% downside from pre-report levels; core claim is that MRAM is substitution-driven niche memory for industrial/embedded persistence, solving a different problem than the HBM/DRAM running AI clusters.
- Revenue stagnant in the $50–65M/yr range for years; 14% YoY growth does not justify a >300% re-rating.
- Insider distribution is one-directional: $3.9M sold last quarter with zero buys, then Director Finch's 310,091 shares / $8.52M (~$27.47) on 06-02-2026 selling straight into the squeeze.
- The headline $0.40 Q1 EPS (vs $0.01 est) was inflated by one-time $2.1M defense other-income; the underlying result was still a $0.3M net loss.
- Price sits above every sell-side PT even after the 06-06 drop to ~$23, leaving the $14–$18 cluster as the mean-reversion target.
Setup & Price Structure
- 52-week range $5.64–$51.50; the May parabola topped well below the high and is now marking down.
- 06-04 ~$29.25 → 06-06 traded $23.03–$27.99 and closed ~$23.05, a wide distribution day that broke the parabolic structure.
- No clean higher-low base has formed; the stock is stretched far above any rising moving average after the run, with momentum now negative.
- Trading above all analyst PTs ($17.5–$18.5) into a short-report-plus-insider-sale backdrop the path of least resistance is toward the $14–$18 zone.
- Structure reads as a post-parabolic markdown with active short pressure, not a pullback to support inside an uptrend.
Catalyst Calendar (next 30 days)
- Q2 2026 earnings: NOT in the window. Q1 was reported 2026-04-29; the Q2 print is expected ~late July (~2026-07-28, est.).
- No FDA/PDUFA, no scheduled product launch in window UNISYST 128Mb/256Mb parts are H2 2026, samples late 2026.
- Open-ended risk, not scheduled: further insider Form 4 sales (pattern active through 06-02) and any Kerrisdale follow-up.
- No dated binary catalyst inside the next 30 days.
What Would Change Our Mind
- A genuine AI/datacenter design win with a named customer (not casino gaming or generic industrial) the one thing that would validate the premium the short report attacks.
- Revenue breaking decisively above the $50–65M/yr band: a Q2 actual above ~$17M or a raised FY guide.
- Insider buying replacing the current distribution pattern.
- Technically, a clean higher-low base that reclaims the 20-EMA after the markdown not a reflexive bounce off a falling knife.
- Absent those, strength here is distribution to exit, and the watch stays defensive.
Correlation Notes
- Trades with the small-cap-ai-momentum / memory-squeeze cohort it appeared alongside on 05-11 (GSIT, NVEC and the speculative IT-mover baskets), driven by retail flow rather than semis fundamentals.
- High beta to risk-on/risk-off retail sentiment; behaves like a squeeze name, decoupled from its own income statement.
- Short-seller-targeted microcap with a tight float single-headline gap risk in both directions, amplified by ongoing insider supply.
Notes
- Q1 2026 reported 2026-04-29; Q2 print expected ~late July (~2026-07-28 est.) outside most 30d windows. Apply earnings blackout ~3 trading days before the Q2 print.
- Reclassified →6 (retail squeeze): parabolic microcap with an active short-seller battle (Kerrisdale, $14 PT) + heavy retail flow → tight 1%/name cap applies; auto-trim discipline at RSI>82 if ever long.
- Insider distribution is the key tell: $3.9M sold last quarter with zero buys, then Director Lawrence Finch 310,091 sh / $8.52M on 06-02-2026 (~$27.47).
- Sell-side avg PT $18 (range $17.5–$18.5); Kerrisdale $14. Price still above BOTH after the 06-06 drop to ~$23 no margin of safety on a long.
- Bull case hinges on AI-memory association, which is exactly the claim Kerrisdale dismantles (largest end market = casino gaming/slot machines). Needs a non-casino datacenter design win to re-rate.
- Q1 $0.40 EPS was inflated by one-time $2.1M defense other-income; underlying was a $0.3M net loss. Revenue stuck in the $50–65M/yr band for years.
Related · shared themes
AIP
Arteris, Inc.
Semiconductor-IP royalty re-accel is now confirmed: Q1 (reported 2026-05-12) revenue +39% and variable royalties +67% YoY drove a near-2x re-rate to a $38.99 ATH plus PT hikes (Rosenblatt $38, Jefferies $35). Fundamentals ACCELERATING, but sell-side has caught up and price sits ~2x off April lows after a -7.8% June 5 pullback fresh entry rates MEDIUM, cleaner on a 20-EMA hold (low $30s) or a >$39 breakout than chasing here.
DUOT
Duos Technologies Group, Inc.
Railcar-inspection microcap re-rated as an AI edge data-center/GPUaaS operator; the 2026-06-05 USD.AI $98.1M non-dilutive, off-balance-sheet facility funds the 2,304 B300 GPUs for the $176M Hydra Host contract, gutting the dilution bear case and signaling offtake demand exists. Theme ACCELERATING, ~$14 near highs, RSI ~58 but still a 2H-2026 execution bet against a $2.72M Q1 base.
EVC
Entravision Communication
Broadcaster-to-adtech pivot validated: Q1 (5/5) ATS/Smadex revenue +204% YoY to $154.55M, swing to $20.7M op income, EPS $0.13 vs -$0.53. Accelerating fundamental leg, but no 30-day catalyst and the TelevisaUnivision affiliation expiry (12/31) is the overhang.
AMBQ
Ambiq Micro, Inc.
Edge-AI silicon small-cap. Q1 blowout + Q2 guide-raise (2026-05-12) drove a parabolic to $85.77 ATH (May 26); June 5 -12.4% distribution day is the first crack. Catalyst already fired, now trades above analyst PTs ($70), no catalyst until ~Aug Q2. Wait for a re-setup, don't chase the unwind.